If there was a deal or new deal, I would expect sp

If there was a deal or new deal, I would expect sp spike before.

For financing, just my thoughts, assuming no deal or deal on hold until cancer data and they need to continue selling shares, which may or may not be the case.

Finish BLA & mono investigatory trial. The burn rate drops possibly to 1M per month.
Focus on tnbc, (cheap), prep (get external funding for 1000 patients), get mono pivotal approved, but wait until revenue or other financing. Buys them a couple months at low burn until positive news.